Rahm, Ann-Kathrin
Katus, Hugo A.
Thomas, Dierk
Chapter History
First Online: 11 September 2018
Compliance with Ethical Standards
:
: This work was supported in part by grants from the University of Heidelberg, Faculty of Medicine (Physician Scientist Scholarship to A.K.R.) and the German Cardiac Society (DGK Research Scholarship to A.K.R,), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D.T.), from the German Heart Foundation/German Foundation of Heart Research (F/08/14 to D.T.), from the Joachim Siebenreicher Foundation (to D.T.), and from the Ministry of Science, Research, and the Arts, Baden-Wuerttemberg (Sonderlinie Medizin to D.T.).
: D.T. reports receiving lecture fees/honoraria from Bayer Vital, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer Pharma, Sanofi-Aventis, St. Jude Medical, and ZOLL CMS, and research grant support from Daiichi Sankyo. H.A.K. and D.T. filed a patent application for the use of K<sub>2P</sub> potassium channels for altering cardiac electrophysiology.
: This article does not contain any studies with human participants or animals performed by any of the authors.